Bleeding ‐related hospital admissions and 30‐day readmissions in patients with non‐valvular atrial fibrillation treated with dabigatran versus warfarin
ConclusionWhen compared with warfarin, dabigatran was associated with a comparable incidence of first hospital admission but a higher risk of 30‐day redmission with respect to bleeding. Close early monitoring of patients initiated on dabigatran following hospital discharge for bleeding is warranted.
Source: Journal of Thrombosis and Haemostasis - Category: Hematology Authors: W. C. Y. Lau, X. Li, I. C. K. Wong, K. K. C. Man, G. Y. H. Lip, W. K. Leung, C. W. Siu, E. W. Chan Tags: Original Article Source Type: research
More News: Atrial Fibrillation | Bleeding | Coumadin | Databases & Libraries | Gastroenterology | Hematology | Hong Kong Health | Pradaxa | Study | Thrombosis | Warfarin